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Abstract
  
 Fetal bovine serum (FBS) is a gold standard as a supplement to cell and tissue culture 
media. This is due to a large number of Growth Factor (GF) contained in FBS. However, the 
use of FBS is at risk of transferring endotoxins, prions, bacteria and viruses from animals to 
humans, so it is risky to be used on cell therapy. Human Platelet Lysate (HPL) is a medium 
that can be developed as an alternative cell growth medium. The advantage of HPL is that 
it does not contain aggregate platelets so it does not cause the cells to clot. This condition 
causes HPL to be used as a substitute medium replacing FBS for cell propagation. The use 
of HPL for cell propagation has been widely reported. However, the use of HPL in cancer 
cells has not been found. Thus, this study aims to see the effectiveness of HPL as a T47D 
cell culture medium. The study began with donor selection with criteria for the male sex, 
the blood type O, the age ≤35 years. Furthermore, the Platelet Concentrate (PC) was 
processed into HPL then measured pH, total protein and albumin levels. The cell viability 
was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-dphenyl tetrazolium bromide 
(MTT) assay to determine the ability of cell proliferation when propagation using HPL. The 
doubling time test was carried out as in the cell proliferation test. However, the incubation 
was carried out for 24 h, 48 h and 72 h and the HPL concentration used was 5%. The result 
shows that HPL 10% and 20% ability to increase proliferation better than the FBS 10%. HPL 
with a 5% concentration ability to shortens the doubling time than FBS 10% (doubling time 
is less than 19.94 h). It this study, cell proliferation is influenced by the pH of HPL and total 
protein but not by the amount albumin. 
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INTRODUCTION
 In vitro culture is one of the experiments 
used in various medical tests, one of which is 
anticancer. The development of cell culture has 
an impact on increasing the use of Fetal Bovine 
Serum (FBS). FBS is a supplement of cell culture 
medium containing essential nutrients such as 
protein, Growth Factor (GF), lipids, carbohydrates, 
fats, micronutrients and vitamins that are used to 
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accelerate cell proliferation. It is estimated that the 
need for FBS reaches about 500,000 liters/year. It 
is indicated that more than 1,000,000 cow fetuses 
must be “harvested”. This is very contrary to animal 
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welfare because to get FBS, the mother cow must 
be killed (euthanasia) and the fetus of the cow is left 
for 10-20 minutes before getting the blood. Also, 
the use of FBS can cause  the  risk  of  transferring 
endotoxins, bacteria and viruses from animals 
to humans (Brunne, et al., 2010; AVMA, 2013; 
Witzenedera, et al., 2013). 
 Platelet Concentrate (PC) is a 
blood component used for the treatment of 
thrombocytopenia patients due to bleeding or 
platelet function disorder (Goel, et al., 2015; 
Petraszko, et al., 2016). The ability of platelets to 
regenerate injured cells, blood vessel formation, 
mitogenesis (Durante, et al., 2013) and to regulate 
cell differentiation shows that platelets varied 
Growth Factor and protein contents (Hemeda, et 
al., 2014). Thus, it can be used as an alternative to 
cell culture media.
 Human Platelet Lysate (HPL) is a blood 
component made by repeatedly freezing-thawing 
PC. This is intended to lyse and dispose of platelet 
cell debris to get the growth factors. HPL also 
does not contain aggregate platelets so it does not 
cause cells  to  coagulate  (Hemeda, et al.,  2014; 
Mohammadi, et al., 2016). This is the reason why 
HPL can be used as a substitute media to replace 
FBS for cell culture.
 The T47D cells are breast cancer cell lines 
isolated from breast cancer mammary ducts. The 
existence of p53 gene mutation in this cell line is 
the right model because 70% of breast cancers are 
caused by p53 gene mutation. P53 gene is a type 
of tumor suppressor gene. The mutation of this 
gene causes cells to undergo uncontrolled division 
(Foulkes, et al., 2007; Schafer, et al., 2000; Lies, 
et al., 2007; Varna, et al., 2011) The use of HPL 
for cell culture medium has been widely reported, 
especially for Mesenchymal Stromal Cells (MSC) 
(Lohman, et al., 2012; Fernandez-Rebollo, et al., 
2017). However, there was no report on the use of 
HPL in the cancer cell line. Hence, this research 
is essential to see the effectiveness level of HPL 
for cell line propagation. HPL contains Vascular 
Endothelial Growth Factor (VEGF), Insulin 
Growth Factor (IGF) and Transforming Growth 
Factor (TGF), which play a role in angiogenesis 
and inhibition of apoptosis (Durante, et al., 2013; 
Wen, et al., 2018). This condition is approaching 
in vivo condition, so it is expected to produce more 
accurate doubling time of cancer cells. The use of 
HPL together with anticancer compounds can lead 
to a more optimal dose.
METHODS
 This study has been ethically approved by 
the Ethical Commission of Faculty of Medicine of 
Gadjah Mada University number: KE/FK/0346/
EC/2019. The research was conducted in the 
following stages:
Donor Selection and Blood Screening
 Blood products are strongly influenced by 
the quality of donors. In this study, the sample used 
came from 4 donors. The donor selection process 
was carried out at The Indonesian Red Cross (PMI) 
Yogyakarta City. Hence, the prospective donors 
in this study must pass donor selection under 
Regulation of the Republic of Indonesia Minister 
of Health Regulation No. 91 of 2015. Also, these 
donors shall the following additional criteria which 
include: male, O blood type and less than 35 years 
old. Then, Donors according to the criteria drawn 
their blood to be put in a Triple Bags blood bags 
containing Citrate-Phosphate-Dextrose-Adenine 
(CPDA-1) (JMS PTE Ltd, Singapore). Whole 
blood was then screened for Hepatitis C, Hepatitis 
B, Syphilis and human immunodeficiency virus 
(HIV) with ChemiluminescentImmuno Assay 
(Architech) method. Samples with negative results 
on Hepatitis C, Hepatitis B, Syphilis and HIV (Non-
reactive), whole blood was processed into a PC.
The Making of Blood Component of PC 
 Whole blood was centrifuged using 
Refigenerate Centrifuge blood bags (Kubota) 
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at a speed of 380 g for 15 minutes at 22ºC, 
which would produce Packed Red Cell 
(PRC) and Platelet Rich Plasma (PRP). The 
separation process was improved using a 
plasma extractor (Novomatic, Gumpoldskirchen
Austria). The PRP was then centrifuged again at 
a speed of 3000 g for 12 minutes at 22ºC. This 
process would produce a PC in a 50-70 mL volume 
bag. The PC was then stored in a plasma agitator 
(Helmer, Bergen Boulevard, Noblesville, USA) at 
a temperature of 20-24ºC (Permenkes RI No. 91, 
2015). The Platelet Concentrate was then stored 
for 3 days (sample code: A1 and A2) and 5 days 
(sample code: B1 and B2). In each storage, protein 
and albumin levels were measured. Besides, the 
pH was also measured using a pH meter (Ohaus)
pH Measurement
 The pH level was measured before and 
after making of HPL. The sample was taken as 
much as 2 mL using a syringe and placed in a sterile 
glass tube. Measurement was conducted using a pH 
meter (Ohaus).
Measurement of Protein Content
 A sample of 20 μL was mixed with 1000 
μL of mono reagent total FS  protein  (DiaSys, 
Holzheim, Germany). Then, it was incubated for 5 
minutes at room temperature and had an absorbance 
measurement using a wavelength of 540 nm. The 
total protein was calculated by comparing standard 
values.
 
Measurement of Albumin Levels
 A sample of 10 μL was mixed with 1000 
μL of Albumin FS (DiaSys), then incubated for 10 
minutes at room temperature and had an absorbance 
measurement using a wavelength of 540 nm. 
Albumin levels were calculated by comparing 
standard values.
The Making of HPL
 HPL was made using the PC freezing-
thawing method repeatedly. PC was frozen using 
plasma freezing and thawed using waterbath at 
37°C. The second and third freezing process was 
conducted using deep freezing of -80°C. The results 
of the freezing-thawing  were   then   transferred 
to  a  sterile conical tube for centrifugation using 
4000 rpm for 15 minutes at room temperature. The 
supernatant was then removed and transferred to a 
sterile tube  (carried   out    in   Laminar    Air 
Flow).     The      freezing-thawing process was 
carried out at the Research Laboratory, Faculty 
of Medicine, Universitas Islam Indonesia. 
HPL for each treatment was measured by 
pH meter, total protein content and albumin.
Proliferation  Test  of  HPL as a T47D Cell 
Culture Medium
 Proliferation   test  was  carried  out  at 
Parasitology Laboratory, Faculty of Medicine, 
Universitas Gadjah Mada. The T47D cell stock 
was recultured in the flask and added with the 
Roswell Park Memorial Institute (RPMI) 1640 
media which already contained 2% penicillin and 
streptomycin (penstrep) 0.5% fungizone and 10% 
FBS. Furthermore, the cells were incubated using 
an incubator containing 5% CO2  and temperature 
37°C. Confluent cells were removed from the 
media, washed by Phosphate Buffer Saline (PBS) 
and added with trypsin-EDTA to release cells from 
the flask. The cell suspension was accommodated 
in the conical then centrifuged to eliminate trypsin 
in a medium. Supernatant removed and the 
complete medium is added. The number of cells 
was calculated using a haemocytometer (Freshney, 
2000). Proliferation cell analysis used the cell 
density of 10,000/100 µL (microplate 96 well). The 
Cells that have been calculated for density then 
added RPMI medium which containing HPL 10%, 
penstrep 2% and fungizone 0.5% dan the other 
cell treated using RPMI which containing HPL 
20%, penstrep 2% and fungizone 0.5%. Control 
positive is RPMI with FBS 10%, penstrep 2% and 
fungizone 0.5%. Control negative is cell culture in 
RPMI medium only containing penstrep 2% and 
fungizone 0.5%. 
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 The cell then incubated overnight in the 
incubator CO2, the temperature of 37°C. After that, 
the medium in cell culture was removed, then added 
the PBS 100 µL each well. The PBS was removed 
and then added 100 µL/well 3-(4,5-dimethylthiazol-
2-yl)-2,5-dphenyl tetrazolium bromide (MTT) 
reagents. The cell incubated 2-4 h in the incubator 
CO2. After that add a stopper 100 µL 10% SDS in 0.1 
N HCl. Percentage of cell viability was calculated 
using MTT assay and its absorbance was read with 
ELISA reader (530 nm) and calculated using the 
following formula:
% of viable cells=(Absorbance of treatment-
absorbance of medium)/(absorbance of control-
absorbance of medium)×100%
The Doubling Time Test for the Use of HPL 
on T47D Cell Culture Medium
 The doubling time test was carried out 
as in the cell proliferation test. However, the 
incubation was carried out for 24 h, 48 h and 72 
h and the HPL concentration used was 5%. Each 
incubation was calculated for its absorption 
value. The doubling time value was then analyzed 
by making a regression graph between cell 
viability and incubation time at each treatment.
Statistical Analysis
 The data were analyzed using the SPSS 
21 program. Previously, a normality test was 
performed. The Pearson correlation test was 
conducted to determine the relationship between 
variables (such as age and platelet count; platelet 
count with total protein; the proliferation cell 
with pH, proliferation cell with total protein and 
albumin). The Pair T-Test was conducted to see 
the difference in pH values before and after HPL 
was made. One-Ways ANOVA and LSD test was 
performed to see whether there were differences 
in T47D cell proliferation grown on 10% HPL and 
20% HPL compared with 10% FBS. The doubling 
time was analyzed by a regression equation between 
the number viability of cells with incubation time 
Multi ways-ANOVA and LSD test was performed 
to see the difference in the use of 5% HPL in each 
sample with 10% FBS in the doubling time test.
RESULTS
The Characteristics of Donors
 This stage is carried out to produce good 
quality of HPL because blood quality is influenced 
by donors. The characteristics of donors can be seen 
in Table 1. PC is taken from donors aged 20-30 years 
with a total of samples are 4. Platelet  count can 
affect the quality of HPL, so a platelet count analysis 
is needed. Analysis correlation is needed to find out 
the relationship between age and platelet count. 
The analysis shows that age affected platelet count 
(p=0.04 or p<0.05). The higher the age, the lower the 
platelet count produced (r=-0.956). Table 1 shows 
that sample code B2 from donors aged 20 years had 
the highest platelet count, about 894 (×103 µL).
Table 1. The Characteristics of Donors
The Total Protein and Albumin in HPL
 Protein is one of the macromolecules that 
are very important to regulate cell proliferation, so 
this study measured the total protein in each sam-
ple of HPL. The results of measurements of total 
protein and albumin can be seen in Figure 1. The 
range of total protein is 6.75-8.71 g/dL, the highest 
sample is code B1 (8.71 g/dL) while the lowest is a 
sample with code A1 (6.75 g/dL). Pearson correla-
tion analysis shows that the total protein was not 
affected by platelet count (p=0.714 or p>0.05) and 
age (p=0.806 or p>0.05).
 Albumin is the most abundant protein in 
the blood. The results showed that the sample with 
code A2 had the lowest albumin content of 3.75 g/
dL and the highest is sample B1 about 4.38 g/dL. 
Pearson correlation analysis show that the albu-
min was not affected by platelet count (p=0.605 or 
p>0.05), age (p=0.435or p>0.05) and total protein 
(p=0.332 or p>0.05).
Days of 
storage Sample Code 
Age of Donors  
 (Years old)  
Platelet count (×103 µL) 
3 
A1  20  758  
A2  30  343  
5 
 
B1  24  543  
B2
 20  894  
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Figure 1. The Total protein and albumin content in HPL.
The Value of pH in HPL
 The degree of acidity or pH was measured 
after making HPL. The measurement results show 
that each sample gives different values. There were 
also changes before and after the manufacture of 
HPL. In samples coded A1, A2 and B1, the pH be-
fore being processed into HPL were higher than 
after making HPL. However, this is different in 
samples with code B2, that is the pH before making 
HPL is lower than after making HPL. After mak-
ing HPL, samples with code B1 had the lowest pH 
value of 7.1 and the highest B2 was 7.4 (Figure 2).
The  Proliferation of T47D  in HPL Culture 
Medium
 In this study, T47D cell propagation media 
used HPL with concentrations of 10% and 20%. 
Meanwhile, as a comparison (positive control), 
we used RPMI containing FBS of 10%, penstrep 
2% and fungizone 0.5% and cell control is  T47D 
propagation in RPMI medium, penstrep 2% and 
fungizone 0.5% without FBS or HPL. The results 
of T47D cell proliferation using cell culture media 
can be seen in Figure 3.
 Figure 3 shows that T47D cell growth us-
ing HPL medium with a concentration of 10% or 
20% can increase T47D cell proliferation better 
than FBS 10%.  Code  sample  B1-20   can  in-
crease  proliferation 1.76 times greater than FBS 
10%, while the lowest is a sample with code B2-10 
which is 1.07 times. LSD test results showed that 
samples A1-10, A2-10, A2-20, B1-20, B1-20, and 
B2-20 were significantly different in increasing cell 
proliferation compared with FBS 10%. However, 
there were no significant differences between sam-
ples with codes A1-20 and B2-10 (p>0.05). 
 The proliferation of cells can be caused by 
several factors including pH, the amount of pro-
tein and albumin. So to find out whether there is 
an influence, then the correlation analysis test is 
performed. The results of the analysis of Pearson 
correlation between cell proliferation and albumin 
show a value of 10% HPL p=0.535 and 20% HPL 
p=0.426 (p>0.05). It means no correlation.
Figure 2. The values of  pH before and after made of HPL.
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Figure 3. The percentage of cell growth using HPL 10% and HPL 20% on each storage day. *significant 
(p<0.05). 
The Doubling Time of T47D Cells in HPL Cul-
ture Medium
 The proliferation of cell activity was con-
ducted by the doubling time test by incubating 
T47D cells using HPL for 0, 24, 48 and 72 h. Each 
time, the incubation was measured the number of 
viable cells. The graph of the relationship between 
the number of lives with the duration of the incu-
bation time is seen that there is an increasing num-
ber of cells while increasing the incubation  time. 
However, HPL can increase T47D cell proliferation 
than propagation cells with FBS 10%. The prolifer-
ation of T47D cell using HPL with various incuba-
tion times can be seen in Figure 4.
Table 2. The results for using 10% HPL and 20% HPL 
for the T47D cell proliferation medium for 
each treatment.
Note: *p<0.05 which means there is a significant difference
Independent T-Test was conducted to see whether there was 
a difference in cell proliferation using concentration 10% 
HPL with 20% HPL in each group. The results show that 
only samples with codes B1 and B2 have significant differ-
ences (p<0.05).
Tabel 3. The Pearson correlation analysis between 
Cell Proliferation with others variable (pH, To-
tal protein and albumin).
Note: *p<0.05 which means there is a significant difference.
Table 4.  The Doubling time of T47D cells in each 
treatment is sorted from the fastest time.
Note: Significance value was obtained from the Anova 
Multi-Ways test and continued with the LSD test to see the 
significant use of 5% HPL in each treatment compared to 
the 10% FBS. *p<0.05 which means there is a significant 
difference.
 Figure 4  shows that in the 24th h, the num-
ber of lives increased almost 2 times the number 
of initial cells, especially in samples with codes A1 
and A2. Samples with A2 code can increase T47D 
cell proliferation greater than the others which are 
1.22 times faster than FBS 10%. Meanwhile sam-
ples with A1 code increase cell proliferation by 
1.08 times. Samples B1 and B2 were able to in-
crease cell proliferation 1.05 times and 1.09 times.Sample
 
Code
 
Concentration 
of HPL
 
Mean ±SD
 
Comparison of each 
treatment with FBS 10%
 
Independent 
T-Test Increased cell
 
proliferation 
LSD test
 
A1
 
10 %  208.47±9.26  1 .41 0.017* 
0.471 
20 %  191.67±35.39 1.13  0 .150
 
A2
 
10 %  205.89±6.45  1 .39 0.025* 
0.138 
20 %  226.88±18.58 1.33  0.001* 
B1
 
10 %  260.06±14.29 1.76  0.000* 
0.037* 
20 %  302.98±19.35 1.77  0.000* 
B2
 
10 %  157.90±9.20  1.07 0.469 
0.042* 
20 %  201.57±23.97 1.19  0.044* 
 
Sample
 Code
 
Concentration 
of HPL
 
Mean ±SD
 
Comparison of each 
treatment with FBS 10%
 
Independent 
T-Test Increased cell
 
proliferation 
LSD test
 
A1
 
10 %  208.47±9.26  1.41 0.017* 
0.471 
20 %  191.67±35.39 1.13  0.150
 
A2
 
10 %  205.89±6.45  1.39 0.025* 
0.138 
20 %  226.88±18.58 1.33  0.001* 
B1
 
10 %  260.06±14.29 1.76  0.000* 
0.037* 
20 %  302.98±19.35 1.77  0.000* 
B2
 
10 %  157.90±9.20  1.07 0.469 
0.042* 
20 %  201.57±23.97 1.19  0.044* 
 
Variable  Concentration of HPL 
10% 20% 
Cell Proliferation-pH 0.022* 0.087 
Cell Proliferation-Total Protein  0.338  0.038* 
Cell Proliferation-Albumin  0.475  0.574
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 The doubling timeline is made with the 
regression equation between the numbers of lives 
with the length of time incubating to see the slope 
which is the kinetic parameter of the cellular pa-
rameters (Field, 1996 in Meiyanto, et al., 2003). 
The equation of regression and doubling time value 
can be seen in Table 4.
DISCUSSION
 HPL can be used as an alternative me-
dium for cell culture in vitro. High quality plate-
lets are needed for the production of HPL, which 
is greatly influenced by the condition of potential 
donors. In this study, PC samples were obtained 
from donors with a vulnerable age of  20-34 years 
(<35 years), which aims to reduce the content of 
proteins that can cause aging. The effect of donor 
age was also reported on the use of HPL for the 
propagation of adipose tissue MSC (At-MSC) and 
Bone Marrow-MSC (BM-MSC). In those studies, 
HPL donors were grouped into 3 groups, <35 years 
old, 35-45 years old and >45 years old. The results 
showed that the use of HPL with age <35 years 
caused AT-MCS cell proliferation to be 1.4 times 
faster than the older donor (>45 years). It is because 
the HPL of the donor produces a greater amount of 
susceptibility-associated beta-galactosidase (SA-
β-gal), making it easier to experience informa-
tion reduction, decreased function and ultimately 
death (Lohmann, et al., 2012; Biran, et al., 2017). 
 The Pearson correlation analysis results 
show that there is a relationship between age and 
platelet count (p=0.04 or p<0.05) and the correla-
tion is negative. Younger donors have more plate-
lets. This is consistent with the research of Carlo, et 
al. (2014) that at the age of <34 years has a platelet 
count >260×109 L for a female and >240×109 L 
for a male. However, the number of platelets has 
no effect on the number of growth factors produced 
(Weibrich, et al., 2002; Nugraha, et al., 2014). The 
study of Evanson, et al. (2014) states that at the 
age of ≤25 years the number of Growth Factors is 
higher than the age ≥ of 25 years. Growth factors 
that are increasing are Epidermal Growth Factor 
(EGF), Insulin-like Growth Factor 1 (IGF-1), Plate-
let-Derived Growth Factor-AB (PDGP-AB), Plate-
let-Derived Growth Factor-BB (PDGF-BB) and 
Transforming Growth Factor Beta-1 (TGFP-1). 
 HPL is made using the PC freeze-thawing 
method repeatedly to lyse and dispose of platelet 
cell debris so that growth factors come out (Doucet, 
et al., 2005; Mohammadi, et al., 2016). Platelet 
Concentrate with a variety of storage times was 
first frozen   using   plasma    freezing.    Plasma 
freezing (a cooler containing glycerol) is widely 
Figure 4. The Proliferation of T47D Cell line using alternative medium HPL concentration 5% measured in 
0, 24, 48 and 72 h.
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owned by some The Indonesian Red Cross (PMI) 
because it is used to make the blood component 
of Fresh Frozen Plasma (FFP). The use of plasma 
freezing is a modification of an existing method 
(Hemeda, et al., 2014), usually for freezing HPL 
using deep freezing. Plasma freezing contains 
glycerol so that it can maintain protein structure 
when it is frozen (Pierce, 2003; Vagenende, et al., 
2009) The thawing process uses waterbath at 37°C. 
Freezing 2 and 3 is done using  deep   freezing 
-80°C. In this study, freezing-thawing was done 
3 times. It is because freezing-thawing of 3 times 
can reduce the number of platelets 53% compared 
to freezing-thawing of 2 times and 1 time, respec-
tively 47% and 25%. Also, freezing-thawing 3 
times results in the amount of Vascular endothelial 
growth factor (VEGH), Platelet-derived growth 
factor - AA (PDGF AA), Epidermal growth factor 
(EGF) more than freezing-thawing which is done 
only 2 times (Baik, et al., 2014). The results of 
freezing-thawing are then centrifuged to separate 
the cell debris from the supernatant and HPL can 
be used as an alternative medium for cell growth.
 In vitro culture, cell growth is one of the 
most important stages. In general, cell growth me-
dia use FBS additional supplements. This study 
used an alternative medium, which is HPL for T47D 
cell proliferation using concentrations of 10% and 
20%. The results of cell proliferation measurements 
show  that  the  use  of   HPL  can  increase  cell  pro-
liferation more than the use of 10% FBS. The use of 
low concentrations of HPL has also been reported 
by Cowper, et al. (2019) in Human Adipose-De-
rived Stromal/Stem Cells (ASC). HPL used were 
0.1%, 0.33%, 0.75% and 1%. The result is ASC cell 
proliferation using HPL concentrations of 0.75% 
and 1% can increase ASC proliferation more than 
10% FBS. Meanwhile, the use of HPL concentra-
tions of 0.1% and 0.33% proliferation is lower than 
10% FBS. In this study, the use of 10% HPL and 
20% give a different impact on each treatment for 
T47D cell proliferation. Sample code BI and B2 is 
a significant difference for T47D cell proliferation 
(p<0.05). The sample with code B1 has the best pro-
liferation ability compared to the other samples. This 
might be caused by higher protein content in B1.
 In the doubling time test, the HPL con-
centration used was 5%. It is intended to minimize 
cell death due to interference with the balance of 
the medium. The sample with code B1 has the best 
proliferation ability compared to the other samples. 
It is probably due to the total protein contained in 
HPL. Analysis of bivariate correlation between cell 
proliferation with HPL concentrations used with 
total protein yields a value of p=0.038 (p<0.05) at 
20% HPL, while at 10% HPL a value of p=0.338 
(p>0.05). It means that cell proliferation in the use 
of 20% HPL is influenced by the total protein con-
tained in the sample. It is appropriate because the 
sample having the highest total protein has the best 
ability to increase cell proliferation. Protein is a 
macromolecule that is used as a regulator of me-
tabolism in cells. Proteins can induce proliferating 
cells by increasing the regulation of a cyclin so that 
the cells enter the S/synthesis phase (Cheng, et al., 
2017).
 Albumin is the most abundant protein 
in the blood. Based on in vitro, albumin inhibits 
lipid peroxidation and Reactive Oxygen Species 
(ROS) to keep cells from being damaged (Francis, 
2010). However, in this study, cell proliferation 
of T47D was not influenced by albumin levels.
 B1  sample  produced   the  best  cell   pro-
liferation compared to others, this might be caused 
by a higher protein content in B1. However, the 
doubling time test resulted in B1 has a long time 
compared to sample A2-5%. Sample A2-5% pro-
duces the fastest doubling time of 17.71 h. It is 
likely to be influenced by changes in pH. B1 code 
sample has the pH of 7.1 before being treated in 
the cell, the longer the storage (doubling time test 
takes 72 h) is likely to cause changes in pH. The 
pH value tends to be lower along with the longer 
storage time (Mentari, et al., 2020). The decrease 
in pH along with the length of time of storage may 
be influenced by the process of glycolysis, which 
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is used for cell metabolism (Kholmukhamedov and 
Jobe, 2019). The final process of glycolysis is that 
dissolved CO2 compounds will cause conditions in 
the bag to become acidic, resulting in a decrease in 
pH. The optimum pH value for some cell cultures is 
7.4.
CONCLUSIONS
 HPL can be used as an alternative me-
dium for the cell propagation of T47D, because it 
increases cell proliferation better than 10% FBS. 
Increased cell proliferation will shorten the T47D 
cell doubling time. The proliferation of cell and 
doubling time are affected by pH and total protein.
ACKNOWLEDGMENT 
 This research was funded by Research Grant 
Ministry of Research and Technology 2019 (PDP) 
Contract Number: B/1435.37/L5/RA.00/2019 and 
LPPM STIKES Guna Bangsa Yogyakarta Contract 
number: 09/LPPM_GB/SK/IV/2019.
REFERENCES
AVMA, 2013, FBS and Animal Welfare, American Vet-
erinary Medical Association AVMA Guidelines for 
the Euthanasia of Animals.
Baik, S.Y., Lim, Y.A., Kang, S.J., Ahn, S.H., Lee, W. 
G. and Kim, C.H., 2014, Effects of Platelet Ly-
sate Preparations on the Proliferation of HaCaT 
Cells, Ann Lab Med, 34, 43-50.
Biran, A., Zada, L., Karam, P.A., Vadai, E., Roitman, 
L., Ovadya, Y., Porat, Z. and Krizhanovsky, V., 
2017, Quantitative identification of senescent 
cells in aging and disease, Aging Cell, 16(4), 
661–671.
Brunne, D., Frank, J., Appl, H., Schöffl, H., Pfaller, 
W. and Gstraunthaler, G., 2010, Serum-free Cell 
Culture: The Serum-free Media Interactive On-
line Database, Altex, 27(1), 53-62.
Carlo, L., Balduini and Noris, P., 2014, Platelet Count 
and Aging, Hematologica, 99 (6), 953-955.
Cheng, X.M., Xu, X., Liu, J., Mei, B., Fu, P. and Zhao, 
D., 2017, Panax ginseng total protein pro-
motes proliferation and secretion of collagen 
in NIH/3T3 cells by activating extracellular sig-
nal-related kinase pathway, Journal of Ginseng 
Research, 41(3), 411-418.
Cowper, M., Frazier, T.,  hy, X., Curley, J.L., Ma, 
M.H., Mohiuddin, O.A., Dietrich, M., McCarthy, 
M.,  Bukowska, J. and  Gimble, J.M., 2019, Hu-
man Platelet Lysate as a Functional Substitute 
for Fetal Bovine Serum in the Culture of Human 
Adipose Derived Stromal/Stem Cells, Cells., 
8(7), 724.
Doucet, C., Ernou, I., Zhang, Y., LIense, J-R., Begot, 
L., Holy, X. and Lataillade, J-J., 2005, Platelet 
lysates promote mesenchymal stemcell expan-
sion: A safety substitute for animal serum in 
cell-based therapy applications, Journal of Cel-
lular Physiology, 205(2), 228-236.
Durante, C., Agostini, F., Abbruzzese, L., Toffola, 
R.T., Zanolin, S., Suine, C. and Mazzucato, 
M., 2013, Growth factor release from platelet 
concentrates: analytic quantification and char-
acterization for clinical applications, VoxSan-
guinis, 105(2), 129-136.
Evanson, R., Guyton, K. and Oliver, D.L., 2014, Gen-
der and Age Differences in Growth Factor Con-
centrations From Platelet-Rich Plasma in Adults, 
Military Medicine, 179(7), 799.
Fernandez-Rebollo, E., Mentrup, D., Ebert R., Fran-
zen, J., Abagnale, G., Sieben, T., Ostrowska, A., 
Hoffmann, P., Roux, P-F., Rath, B., Goodhardt, 
M., Lemaitre, J-M., Bischof, O., Jakob, F. and 
Wagner, W., 2017, Human Platelet Lysate ver-
sus Fetal Calf Serum: These Supplements Do Not 
Select for Different Mesenchymal Stromal Cells, 
Scientific Reports, 7, 5131.
Foulkes, W,D., 2007, Gene p53 Master and Com-
mander, The New England Jurnal of Medecine, 
357(25), 2539-2541.
Francis, G.L., 2010,  Albumin and mammalian cell 
culture: implications for biotechnology applica-
 45
Indonesian Journal of Cancer Chemoprevention, February 2020
ISSN: 2088–0197
e-ISSN: 2355-8989
tions, Cytotechnology, 62(1), 1–16.
Freshney, R,I., 2000, Culture of Animal Cells: A manual 
of Basic Techniques, 4th Ed Wiley- Lies. Canada.
Goel, R., Ness, P.M., Takemoto, C.M., Krishnamurti, 
L., King, K.E. and Tobian, A.A., 2015, Platelet 
transfusions in platelet consumptive disorders 
are associated with arterial thrombosis and in
-hospital mortality, Blood, 125(9), 1470–1476. 
Hemeda, H., Giebel, B. and Wagner, W., 2014, Eval-
uation of human platelet lysate versus fetal bo-
vine serum for culture of mesenchymal stromal 
cells, Cytotherapy, 16, 170-180.
Kholmukhamedov, A. and Jobe, S., 2019, Platelet res-
piration, Blood Advances, 3(4), 599-602.
Lohmann, M., Walenda, G, Hemeda, H., Joussen, S., 
Drescher, W., Jockenhoevel, S., Hutschenreu-
ter, G., Zenke, M. and Wagner, W., 2012, Donor 
age of human platelet lysate affects prolifera-
tion and differentiation of mesenchymal stem 
cells, PLoS One, 7(5), e37839.
Meiyanto, E., Sismindari, Candra, L. and Moordiani, 
2003, Efek Antiproliferatif Ekstrak Etanol Daun 
dan Kulit Batang Tanaman Cangkring (Erythrina 
fusca Lour.) terhadap Sel HeLa, Majalah Far-
masi Indonesia, 14(3), 124-131. 
Mentari, D., Pebrina, R. and Nurpratami, D., 2020, 
Effect Storage of pH, Glucose Level, LDH, Cal-
cium and MPV as a Quality Indicator of Trombo-
cyte Concentrate, Biomedika, Feb.12 (1).
Mohammadi, S., Nikbakht, M.,  Mohammadi, A,M., 
Panah, M.Z., Ostadali, M.R., Nasiri, H. and 
Ghavamzadeh, A., 2016, Human Platelet Lysate 
as a Xeno Free Alternative of Fetal Bovine Se-
rum for the In Vitro Expansion of Human Mes-
enchymal Stromal Cells, International Journal 
of Hematology-Oncology and Stem Cell Reser-
ach, 10(3), 161-172.
Nugraha, Y., Sari, P., Purwoko, R.Y., Luviah, E. and 
Adiwinata, J., 2014, Effect of lysed plate-
let count in platelet concentrates on various 
growth factor levels after freeze thaw cycles, 
International Journal of PharmTech Research., 
6(7), 2036-2042.
Petraszko, T. and Zeller, M., 2016, Canadian Blood 
Service: Platelet Transfution, Alloimunization 
and Management of Platelet Refractoriness. 
https://profedu.blood.ca/en/transfusion/
clinical-guide/platelet-transfusion-alloimmuni-
zation-and-management-platelet accessed on 
September 10th 2019.
Permenkes RI, 2015, Peraturan Menteri Kesehatan 
Republik Indonesia No. 91 tentang Standar Pel-
ayanan Darah, Jakarta, Retrieved from https://
www.kemhan.go.id/itjen/wp-content/up-
loads/2017/03/bn36-2016.pdf
Pierce, 2003, Technical Resource. Protein stability 
and storage. http://wolfson.huji.ac.il/purifica-
tion/PDF/StorageProteins/PIERCE_ProteinStor-
age.pdf, accces on 10th Sep 2019.
Regulation of the Minister of Health of the Republic 
of Indonesia Number 91 Year 2015 Concerning 
Blood Transfusion Service Standards.
Schafer, J.M., Lee, E.S., O’Regan, R.M., Yao, K and 
Jordan, V.C, 2000, Rapid Development of Ta-
moxifen-Stimulated Mutant p53 Breast Tumors 
(T47D) in Athymic Mice, Clin Cancer Res., 6, 
4373-4380.
Vagenende, V., Yap, M.G and Trout, B,L., 2009,  Mech-
anisms of protein stabilization and prevention 
of protein aggregation by glycerol, Biochemis-
try, 48(46), 11084-96. 
Varna, M., Bousquet, G, Plassa, L-F., Bertheau, P. and 
Janin, A., 2011, TP53 Status and Response to 
Treatment in Breast Cancers, Journal of Bio-
medicine and Biotechnology, 2011(1), 1-9.
Weibrich, G., Kleis, W.K., Hafner, G, Hitzler, W.E, 
2002, Growth factor levels in platelet-rich 
plasma and correlations with donor age, sex and 
platelet count, J Craniomaxillofac Surg, 30(2), 
97-102.
Wen, Y.H., Lin, W.Y., Lin, C.J. and Sun, Y.C., 2018, 
Sustained or higher levels of growth factors in 
platelet-rich plasma during 7-day storage, Clin-
ica Chimica Acta, 483, 89-93.
Witzenedera, K., Lindenmair, A., Gabriela, V. and 
Höllera, K., 2013,  Human-Derived Alternatives 
to Fetal Bovine Serum in Cell Culture, Transfus 
Med Hemother, 40, 417–423. 
